Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 5.23%.
Auxilium Pharmaceuticals Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 37.5% to $0.22 in the quarter versus EPS of $0.16 in the year-earlier quarter.
Revenue: Rose 28.57% to $100.5 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Auxilium Pharmaceuticals Inc. reported adjusted EPS income of $0.22 per share. By that measure, the company beat the mean analyst estimate of $-0.03. It beat the average revenue estimate of $91.43 million.
Quoting Management: “In the second quarter of 2013, Auxilium achieved strong growth and record net revenues, and we are confident of achieving the $20 million synergy target we have set for 2014 from the integration of Actient,” said Adrian Adams, Chief Executive Officer and President of Auxilium. “For the remainder of 2013 and beyond, we will continue to focus on delivering excellence in execution with a new commercial structure and a broader and more diversified product portfolio. We also look forward to the upcoming PDUFA date for XIAFLEX for the treatment of Peyronie’s disease and are planning a potential launch in the U.S. in the fourth quarter, pending FDA approval for this indication.”
Key Stats (on next page)…
Revenue increased 51.88% from $66.17 million in the previous quarter. EPS increased to $0.22 in the quarter versus EPS of $-0.17 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0.05 to $0. For the current year, the average estimate has moved down from a loss of $0.10 to a loss of $0.13 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)